USPTO trademark

SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES

RegisteredUSPTOWord markClass 35Class 36Class 42Class 44

"SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES" is a word mark owned by Hybrid Concepts International, LLC, filed at the USPTO on December 13, 2021. It is registered and covers classes 35, 36, 42 and 44.

Get this data via the API
Official USPTO record
SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES trademark as filed
As filed with the USPTO
Status
Registered
Since May 2, 2023
Filed
December 13, 2021
Registered
May 2, 2023
Expires
Not recorded
Application no.
97169506
Registration no.
7040283
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES

The owner and representative on file with the office.

Owner

Hybrid Concepts International, LLC

Grand Island, United States

Representative

John P. Murtaugh

Pearne & Gordon LLP

Goods and services

What the mark covers

The products and services SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES is filed for, grouped by Nice class.

  • Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations

  • Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products

  • Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics

  • Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Notification of non-final action e-mailed

8 earlier steps on the official record.

FAQ

About SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES

Who owns the trademark "SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES"?

The USPTO trademark "SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES" (application 97169506) is owned by Hybrid Concepts International, LLC.

What is the status of "SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES"?

Its status at the USPTO is: registered.

When was "SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES" registered?

It was registered on May 2, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d29f8-05d4-74f3-b5a6-4e6a03277525
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d29f8-05d4-74f3-b5a6-4e6a03277525",
  "object": "trademark",
  "mark_text": "SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97169506",
  "filing_date": "2021-12-13",
  "nice_classes": [
    35,
    36,
    42,
    44
  ],
  "owners": [
    {
      "name": "HYBRID CONCEPTS INTERNATIONAL, LLC",
      "entity_id": null
    }
  ]
}